Abbott (ABT)

• Market cap: $201B
• 1 day: 0.76%
• 5 days: -0.89%
• 1 month: -0.13%
• 3 months: 4.47%
• 6 months: 10.81%
• Year to date: 5.51%
• 1 year: 18.27%
• 5 years: 35.22%
• 10 years: 165.16%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Employees: 114,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

7% more funds holding in top 10

Funds holding in top 10: 58 [Q2] → 62 (+4) [Q3]

6% more call options, than puts

Call options by funds: $1.1B | Put options by funds: $1.04B

4% more capital invested

Capital invested by funds: $141B [Q2] → $146B (+$5.28B) [Q3]

1% less funds holding

Funds holding: 2,804 [Q2] → 2,786 (-18) [Q3]

9% less first-time investments, than exits

New positions opened: 183 | Existing positions closed: 201

4.15% less ownership

Funds ownership: 77.88% [Q2] → 73.73% (-4.15%) [Q3]

11% less repeat investments, than reductions

Existing positions increased: 1,031 | Existing positions reduced: 1,153

Research analyst outlook

15 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $117 1% upside
• Avg. target: $130 12% upside
• High target: $149 29% upside

15 analyst ratings

• positive: 11 73%
• neutral: 4 27%
• negative: 0 0%

Barclays Matt Miksic 69% 1-year accuracy 22 / 32 met price target	29% upside $149	Overweight Maintained	5 Nov 2024
Bernstein Lee Hambright 100% 1-year accuracy 1 / 1 met price target	19% upside $138	Outperform Maintained	17 Oct 2024
UBS Danielle Antalffy 55% 1-year accuracy 6 / 11 met price target	26% upside $146	Buy Maintained	17 Oct 2024
Jefferies Matthew Taylor 25% 1-year accuracy 1 / 4 met price target	8% upside $125	Hold Maintained	17 Oct 2024
Mizuho Anthony Petrone 56% 1-year accuracy 22 / 39 met price target	12% upside $130	Neutral Maintained	17 Oct 2024